Oncology

All articles by Oncology

Aiming to trim costs and bolster U.S. business, Novartis restructures
Aiming to trim costs and bolster U.S. business, Novartis restructures
Marc Iskowitz
April 4, 2022
1:19 pm

The drugmaker is fusing its pharma and oncology units into one business.

80% of oncologists find cancer advertising valuable, new report finds
80% of oncologists find cancer advertising valuable, new report finds
Lecia Bushak
February 16, 2022
2:00 pm

Per a new Syneos report, 80% of oncologists believe cancer advertising helps them make more informed treatment decisions.

Aravive adds three to board of directors
Aravive adds three to board of directors
Larry Dobrow
May 24, 2021
9:00 am

The clinical-stage oncology company is developing a range of therapies.

Oncology competition spotlights non-medical solutions that can close patient-support gap
Oncology competition spotlights non-medical solutions that can close patient-support gap
Marc Iskowitz
November 8, 2019
4:49 pm

Pharma has struggled to align patient services with the needs of disease communities. Open innovation represents one approach towards closing the gap.

Marketing is fueling the march toward precision oncology, says Caris chief commercial officer
Marketing is fueling the march toward precision oncology, says Caris chief commercial officer
Marc Iskowitz
October 10, 2019
10:03 am

Oncology is moving toward a future in which treatments are genetically matched to patients’ tumors. But we won’t get there without generating a lot more awareness about molecular diagnostics, says Caris’ commercial chief.

Oncology leads the charge in pharma Q1 earnings
Oncology leads the charge in pharma Q1 earnings
Alison Kanski
April 25, 2019
3:10 pm

Q1 earnings from Bristol-Myers Squibb, Bayer, Johnson & Johnson, AbbVie and Novartis showed strong growth by oncology drugs.

Specialty Summits | Cardinal Health
Specialty Summits | Cardinal Health
MM&M Content Lab
November 30, 2018
9:46 am

Maximize your engagement with specialty providers and gain valuable insights on their perspectives through Cardinal Health’s Specialty Summits.

Five things for pharma marketers to know: Friday, August 31, 2018
Five things for pharma marketers to know: Friday, August 31, 2018
Carrie Gavit
August 31, 2018
10:22 am

AstraZeneca’s lupus drug fails to meet goals; FDA expands investigation into heart drugs; Lilly names new head of Oncology.

A tale of two lung cancer immunotherapies: Merck’s Keytruda takes the reins
A tale of two lung cancer immunotherapies: Merck’s Keytruda takes the reins
Laura Entis
May 2, 2018
9:00 am

Opdivo’s commercial potential will likely take a hit in the wake of new Keytruda data, but the impact may depend on the ability of BMS to market the message that its I-O/I-O combo allows patients to delay chemo.

Has DTC in the oncology space kept up with science?
Has DTC in the oncology space kept up with science?
Larry Dobrow
March 8, 2018
12:00 pm

As oncology drugs save or extend the lives of many more patients than anyone could have imagined a few years ago, a new challenge has emerged in the wake of their approval: Selling them to patients scared about their prognosis and alternately ignorant of and skeptical about recent breakthroughs in treatment.

  • From Our Partners